Skip to content

The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes

The Effects of Barberry Juice Consumption on Glycaemic Control, Lipid Profile, Blood Pressure and Oxidative Stress in Patients With Type 2 Diabetes: A Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03299153
Enrollment
46
Registered
2017-10-02
Start date
2016-12-21
Completion date
2017-08-05
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

The aim of this study was to investigate the effect of barberry juice (BJ) as a natural antioxidant, on cardiovascular risk factors in patients with type 2 diabetes (T2DM). In a randomized clinical trial study, 46 T2DM patients, 30-70 years old recruited from Diabetes Association of Iran-Babul . Patients were randomly allocated to either the BJ group (n=23) who consumed 200 ml of BJ daily for eight weeks, or the control group (n=23) with no intervention. At the baseline and the end of 8-week intervention, blood pressure and biochemical markers were conducted.

Interventions

OTHERbarberry juice

Sponsors

National Nutrition and Food Technology Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Fasting blood glucose\>100 mg/dL (5.6 mmol /L) * Systolic blood pressure\>130 mmHg or diastolic blood pressure\>85mmHg * Triglycerides\> 150 mg/dL (1.7 mmol/L)

Exclusion criteria

* taking insulin * smoking * using antioxidant supplements

Design outcomes

Primary

MeasureTime frame
fasting blood glucose8 weeks
total cholesterol8 weeks

Secondary

MeasureTime frame
Diastolic BP8 weeks
LDL- cholesterol8 weeks
HbA1c8 weeks
Triglyceride8 weeks
HDL- cholesterol8 weeks
Systolic BP8 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026